Cargando…

Glucose Control and Cardiovascular Disease: Is it important? No

Detalles Bibliográficos
Autores principales:	Conget, Ignacio, Giménez, Marga
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Diabetes and Cardiovascular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811449/ https://www.ncbi.nlm.nih.gov/pubmed/19875576 http://dx.doi.org/10.2337/dc09-S334

Ejemplares similares

Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
por: Blanco, Jesús, et al.
Publicado: (2011)

Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Giménez, Marga, et al.
Publicado: (2012)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Shifting the Disease Management Paradigm From Glucose: What are the cons?
por: Hanefeld, Markolf, et al.
Publicado: (2009)

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
por: Versari, Daniele, et al.
Publicado: (2009)

Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
por: Mannucci, Edoardo, et al.
Publicado: (2013)

Getting to the “Heart” of the Matter on Diabetic Cardiovascular Disease: “Thanks for the Memory”
por: Cefalu, William T., et al.
Publicado: (2016)

Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines
por: Gallwitz, Baptist
Publicado: (2009)

Hypoglycemia and Cardiovascular Risks
por: Frier, Brian M., et al.
Publicado: (2011)

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes
por: Davidson, Jaime A., et al.
Publicado: (2009)

Is Hyperglycemia a Cardiovascular Risk Factor?
por: Pistrosch, Frank, et al.
Publicado: (2011)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
por: Bianchi, Cristina, et al.
Publicado: (2009)

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
por: Schnell, Oliver, et al.
Publicado: (2009)

Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes
por: Viñals, Clara, et al.
Publicado: (2019)

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
por: Gori, Mauro, et al.
Publicado: (2016)

Heart in Diabetes: A Microvascular Disease
por: Laakso, Markku
Publicado: (2011)

Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011)

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
por: Hanssen, Nordin M. J., et al.
Publicado: (2020)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus
por: Biagi, Lyvia, et al.
Publicado: (2018)

A Summary of the ADVANCE Trial
por: Heller, Simon R.
Publicado: (2009)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011)

Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Should C-Reactive Protein Be a Target of Therapy?
por: Oh, Jisun, et al.
Publicado: (2011)

Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain
por: Conget, Ignacio, et al.
Publicado: (2016)

Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump
por: Viñals, Clara, et al.
Publicado: (2020)

Prediction of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes under Multiple Daily Injections Using Continuous Glucose Monitoring and Physical Activity Monitor
por: Bertachi, Arthur, et al.
Publicado: (2020)

Impact of physical activity on the association of overweight and obesity with cardiovascular disease: The Rotterdam Study
por: Koolhaas, Chantal M, et al.
Publicado: (2017)

Genetic liability to insomnia in relation to cardiovascular diseases: a Mendelian randomisation study
por: Yuan, Shuai, et al.
Publicado: (2021)

Bone mineral density and risk of cardiovascular disease in men and women: the HUNT study
por: Bhatta, Laxmi, et al.
Publicado: (2021)

The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring
por: Mesa, Alex, et al.
Publicado: (2020)

Household availability of dietary fats and cardiovascular disease and mortality: prospective evidence from Russia
por: Stefler, Denes, et al.
Publicado: (2021)

State-level economic uncertainty and cardiovascular disease deaths: evidence from the United States
por: Kyriopoulos, Ilias, et al.
Publicado: (2023)

How does childhood maltreatment influence cardiovascular disease? A sequential causal mediation analysis
por: Soares, Ana G, et al.
Publicado: (2021)

The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women
por: Timpka, Simon, et al.
Publicado: (2018)

Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis
por: Dhana, Klodian, et al.
Publicado: (2016)

Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
por: Petersohn, Svenja, et al.
Publicado: (2020)

Vegetable nitrate intake, blood pressure and incident cardiovascular disease: Danish Diet, Cancer, and Health Study
por: Bondonno, Catherine P., et al.
Publicado: (2021)

Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
por: Rios, Paola, et al.
Publicado: (2013)

Association between physical activity and sub-types of cardiovascular disease death causes in a general population cohort
por: Hamer, Mark, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a2upcnrj4jf2elbj6plid45ar3